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Abstract
Background: Sub-Saharan Africa reports low use of family planning methods and high unmet need. Availability of
these methods is one of the major barriers to contraceptive use in the region. This study determined the availability of
modern contraceptives and perceived factors affecting this in health facilities in the Ga East municipality of Ghana.
Methods: This was a cross-sectional study involving quantitative and qualitative techniques. Data was obtained from
51 randomly selected health facilities using a checklist. Relationships between certain attributes of the facilities and
availability of each category of contraceptive identified was tested using univariate and and multiple logistic regression
techniques. The qualitative data was obtained by conducting in-depth interviews with the managers of the facilities
and then analysed according to emerging themes.
Results: The study gave an indication that there was a low availability of long acting reversible contraceptives (LARC)
such as implants (14 %) and IUDs (14 %) in the health facilities. Male condoms (78 %) and combined oral
contraceptives (82 %) were the most available At the bivariate level, emergency contraceptives were less likely to be
found in public health facilities (OR = 0.11, p = 0.05). Facility managers cited ‘profit’ and ‘preference’ as some of the
reasons for availability of their contraceptives.
Conclusion: Availability of modern contraceptives differ according to the type and brand of contraceptive. There is
however a low availability of LARC methods in all the health facilities. Factors such as ‘profit’ accounted for the low
availability of this method.
Keywords: Availability, Contraceptives, Factors, Health facilities
Background
Various studies conducted show that unintended pregnan-
cies and related consequences such as abortion are as a re-
sult of reasons such as low availability and non-use of
contraceptives [1–3]. Sub-Saharan African (SSA) countries
are the most affected as they have persistent high rates of
unmet need for family planning and low contraceptive use
[4–6]. Countries such as Tanzania and Nigeria record high
unmet needs and low contraceptive use [7, 8].
In Ghana, the modern contraceptive prevalence as
reported by the Ghana Health Demographic Survey [9]
was as low as 17 % with unmet need of family planning
for women between 15 and 49 years at 35 % and total
fertility rate (TFR) at 4.0. Ghana was one of the first
African countries to adopt and formulate a National
Population Policy in 1969 which was revised in 1994.
The revised national policy states the aims of the fam-
ily planning component in the reproductive health
policy and these include: provision of information to
individuals as well as making available a full range of
safe and effective contraceptive methods [10].
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The Ghana Demographic and Health Survey [9] has
awareness of modern contraceptives amongst women of
reproductive age at 98 %. The use of these methods varied
according to the commodity, with injectables and pills as
the most preferred methods. Information on the availabil-
ity of these family planning commodities in health facil-
ities in Ghana is however limited [9]. The importance of
making available family planning commodities in order to
improve contraceptive use and family planning coverage
in Ghana is emphasized in a recently released Ghana
Millennium Development Goals Acceleration Frame
work and Country Action Plan [11].
The Ghana Millennium Development Goals frame-
work states “making available family planning commod-
ities in health facilities” one of the major bottlenecks
that needs to be addressed in order to improve maternal
health in Ghana [11]. Making available family planning
commodities is also linked with improved accessibility to
family planning, increased family planning coverage as
well as acceptability of these methods; all these lead to
improved maternal and neonatal health [11].
Ghana is known for operating a pluralistic health system
which is guided by policies and legislations such as the
Ghana Health Service and Teaching Act 525 amongst
others [12]. Health care in the country is obtained primar-
ily from two main providers: the private and the public.
Private providers in Ghana usually include ‘not for profit’
organizations and private practitioners who operate pri-
vate health facilities such as clinics, pharmacies and
licensed chemical shops [12, 13]. Private health facilities
in Ghana such as pharmacies obtain their medical supplies
and other required logistics primarily from registered
private organizations such as pharmaceutical companies
[13]. Public providers on the other hand are associated
with government institutions such as public hospitals,
health centres and the community-based health planning
and services (CHPS) [13]. Public health facilities in Ghana
obtain their medical supplies and other required logistics
primarily from the Ghana medical stores [14, 15]. Health
care from private providers is perceived to be better than
public health care [13]. It is estimated that more than fifty
percent (50 %) of Ghanaians obtain their health care
including contraceptives from private providers [15].
This study sought to assess the availability of mod-
ern contraceptive methods in public and private
health facilities and factors affecting this as perceived
by facility managers in the Ga East municipality. A
comparative analytical approach was used to measure
this outcome.
Methods
Study design
A cross-sectional design was used allowing for a com-
parative analytical approach. A mixed-methods approach
involving quantitative and qualitative data collection
techniques was used.
Study area
Ghana is divided into districts, municipalities and me-
tropolis Data for the study was collected in the Ga East
municipality, a predominantly peri-urban community lo-
cated in the Greater Accra region of Ghana [16]. The
rapidly developing population makes it ideal to study.
The municipality is made up of four sub-municipalities
with a total population of 320,853 and over 100 health
facilities ranging from hospitals and clinics to pharma-
cies and licensed chemical shops [16].
Sampling methods and data collection
The health facilities in the municipality served as the
sampling frame for the study. For the purposes of the
comparative analytical approach, the health facilities
were first divided into two broad arms: private and
public health institutions. These two broad arms were
made up of four major types of health facilities de-
pending on the level of care each facility provided.
These four types of health facilities were the only
available health facilities where clients could obtain
family planning commodities in the district. The four
types were: hospitals, clinics//maternity homes/health
care centres, pharmacies and licensed chemical shops.
A sample of 51 facilities from an estimated 150 health
facilities were used. These were made up of 43 private
and 8 public health facilities.
The municipality had only eight public health facilities
where family planning services were rendered and all
were used for this study. For the private institutions, a
total of three different lists covering all the private health
facilities in the municipality was employed to select the
final sample. The first list comprising all maternity
homes/clinics/ health centres and hospitals in the muni-
cipality where family planning services were provided
was obtained from the municipality’s health directorate
in Abokobi, the capital of the municipality. Health facil-
ities where family planning services were not provided
were excluded from the list.
The municipality’s health directorate could not provide a
clear cut list for pharmacies and chemical shops. However,
they were instrumental in the acquisition of two representa-
tive lists covering all pharmacies and chemical shops. These
were obtained from the government facilities in the four
sub-municipalities under the municipality.
The three different lists showed that pharmacies pro-
vided the most number of private health facilities with
hospitals providing the least. The forty three (43) private
facilities used were distributed as follows: pharmacies 20
(45 %), chemical shops 13 (35 %), clinics/polyclinics/
health centres/maternity homes 7 (15 %) and hospitals 3
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(5 %). This was in accordance with the proportion each
category of health facility contributed.
Simple random sampling was employed to select from
each of the three lists the required number of facility under
each category. With the help of the community health
nurses in the respective sub-municipalities, each of the ran-
domly selected facilities under the various categories was
located and the availability of modern contraceptives in that
facility determined using a checklist. We adopted and
adapted a previously used checklist in a related study [17].
The current study’s checklist, which was pre-tested in a few
selected health facilities outside the study area, had four
main sections with corresponding questions ranging from
the age and sex of the respondent to the name and location
of the health facility. The checklist defined availability of a
contraceptive as follows:
For a contraceptive to be available, the facility manager
first of all indicated that the facility had that contraceptive
in stock as in Bowen et al. [17]. Additionally, the current
study impressed upon facility managers to provide evi-
dence; and this was observed by the trained data collec-
tion personnel. Finally, for each type of contraceptive, the
trained personnel ensured that the quantity in stock met
the minimum contraceptive stock level for that facility.
The facility manager present in each selected facility
was also interviewed by a trained personnel and the inter-
view recorded. The in-depth interview guide used by the
trained personnel also had four main sections covering
key indicators such as factors affecting availability and cost
of modern contraceptives in the facility. A total of 51 in-
depth interviews (IDIS) were conducted amongst the facil-
ity managers.
Power calculations
A descriptive study by Bowen et al. [17] provided infor-
mation on the availability of male condoms and IUDs in
the municipality and this was used in the calculating the
sample size. The availability of male condoms in the
government health facilities was 71 % whilst that of the
private health facilities was 25 %. Given the lack of data
on the other modern contraceptives, this was used as a
proxy. Using a 95 % confidence level and a statistical
power of 80 %, the minimum sample size of 48 was ob-
tained [18] as illustrated below. At the end of the study
however, 51 facilities participated.
Sample size calculations (illustration)
Data analysis and management
A comparative assessment of the two groups, private and
public health facilities was done after data entry and clean-
ing. We used univariate analysis to generate descriptive tab-
ulations for key variables. Statistical tools such as frequency
distribution tables and cross tabulation were used to com-
pare the availability of modern contraceptives in public and
primary health facilities. Analysis looking at the associations
between certain attributes of the facilities (type, place, and
average number of clients per day) and the main outcome
variable, availability of each category of contraceptive iden-
tified, was tested using logistic regression. Associations
were assessed using multiple logistic regression techniques,
where odds ratios (ORs) and their 95 % confidence intervals
(CI) were computed. We employed a standard logistic
regression modelling in SPSS (the “Enter” method) in our
analysis. With this method, all the variables previously
reported to be associated with the outcome variable or
found to be associated with the outcome during the bivari-
ate analysis were entered and a full model generated in a
single step. A key attribute of each model (R2) are included
in Table 2. P value <0.05 was used to denote statistical
significance. All analyses were performed using IBM SPSS
Statistics for Windows, Version 20.0.
The key outcome variables assessed in this study was
fertility intentions/childbearing desires (the desire to a
child or children in the near future), awareness and use
of contraceptives (being aware of and usage of various
contraceptive options available to HIV-positive women).
For the qualitative aspect, the running notes from the
in-depth-interviews were written into expanded notes.
The audio recordings were also transcribed and read
several times to clean the data. The information col-
lected was listed in Microsoft word 2010 and then cate-
gorized manually into emerging themes. The themes
were not determined prior to the start of the study.
Ethical approval and informed consent
Ethical clearance was obtained from the Ghana Health
ervice Ethical Review Committee of the Research and
Development Division of the Ghana Health Service. In
addition to the ethical clearance, permission was also
sought from the Municipal director of the Ga East
municipal health directorate, as well as the facility man-
agers of the various private and public health facilities.
Informed consent was sought from the facility managers
of the various health facilities and it included: the purpose
Key outcome of interest Expected frequency of
outcome in public health
facility
Expected frequency of outcome
in private health farcicality
Confidence
level
Statistical
power
Minimum
Sample size
Availability of modern contraceptives
(male condom used as a proxy)
71 % 25 % 95 % 80 % 48
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of the study, the risks and benefits, privacy and confidenti-
ality as well as conflict of interest.
Results
Background characteristics
The health facilities in Ga East where contraceptives are
sold were identified and categorized into two broad
groups: public and private health facilities. The public
health facilities were eight (8) in number and they in-
cluded one (1) hospital, seven (7) health centres/clinics/
polyclinics. The private health facilities used were 43 in
number and these were: 13 chemical shops, 20 pharma-
cies, 3 hospitals and 7 health centres/maternity homes/
clinics.
Range and brand of contraceptives
Eleven different categories of contraceptives in the munici-
pality were identified and distributed in the health facilities
as follows: combined oral contraceptives (82 %), progestin
only pills (18 %), emergency contraceptives (49 %), proges-
tin only injectable (35 %), monthly injectable (22 %), sper-
micides (39 %), female condoms (4 %), male condoms
(78 %), copper intra-uterine devices (14 %), implants (14 %)
and the ovulation predictor (2.3 %). The common brands
under each category of contraceptives available in the facil-
ities include: Microgynon, Secure, Depo Provera, Postinor 2,
Champion condom and Norigynon. These brands were
available in more than one of the health facilities visited
(Table 1). Male condoms had the most brands available
(37) but they were specific to certain facilities. The long act-
ing reversible contraceptives (LARC) such as implants and
IUDs had as well as the female condoms had only one
brand available (Table 1).
Availability of contraceptives in public and private health
facilities
The most available modern contraceptive in the health
facilities was the combined oral contraceptives. Eighty
four (84 %) of private facilities had oral contraceptives
compared to (75 %) of public facilities (Fig. 1). The pub-
lic hospital available in the municipality (100 %) and
(71 %) of the public clinic/maternity had these oral
contraceptives. Comparatively, all the pharmacies in the
municipality (100 %) and 92 % of the LCS also had these
oral contraceptives. Only 33 % of the private hospitals
and 43 % of the private clinics/maternity in the munici-
pality had these oral contraceptives. There was no statis-
tically significant relationship between availability of
combined oral contraceptives and the type of health fa-
cility (private/public) (Table 2).
The male condom was another of the modern contra-
ceptives that was highly available in the Ga East munici-
pality. Seventy nine (79 %) of private facilities had male
condoms compared to (75 %) of public facilities (Fig. 1,
Table 1). The male condoms were mostly available in
pharmacies (95 %) and LCS (92 %). Only 33 % of the
private hospitals and 28 % of private clinics/maternity in
the municipality had these male condoms. Comparatively,
Table 1 Brand of contraceptives in private and public health facilities
Type of contraceptive Private health facilities Public health facilities
Hospital Pharmacy LC S Clinic/H.C/M. H Hospital Clinic/H.C/M.H/P. C
Combined oral contraceptives Frequency (n = 43) Frequency (n = 8)
Microgynon – 1 – 2 1 5
Secure 1 19 12 1 – –
Emergency contraceptive
WhitePostinor2 – 11 8 – – 1
GreenPostinor2 – 8 1 – – –
Long term contraceptives
Jadelle 1 – – 3 – 3
Copper IUD 2 – – 3 – 3
Injectables
Depo Provera 2 1 – 7 1 7
Norigynon 1 – – 2 1 7
Condoms
Female condoms – – – 1 – 1
Be Safe – 9 5 1 1 4
Protector plus – 14 7 1 – –
Lubricated 1 5 2 – – 2
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(71 %) of the public clinic/maternity homes and the
public hospital (100 %) had the male condoms. From
the multiple regression analysis, there was no associ-
ation between availability of male condoms and type of
health facility (private /public).
The perceived reasons for the high availability of con-
doms in pharmacies and LCS was summed up by one of
the facility managers as follows:
“People are learning and they want to protect
themselves so most of these men go for condoms”
(chemical shop assistant).
All (100 %) public health facilities (both hospitals
and clinics/maternity homes) had both the 3-month
injectable and the monthly injectable available. The 3-
months injectables was also available in all (100 %) of
private clinic/maternity and 75 % of private hospitals.
None of the LCS visited had the 3-months injectables
whilst (5 %) of pharmacies had them available. The
monthly injectables was not available in any of the LCS
and pharmacies whilst 28 % of clinics/maternity homes
and 33 % private hospitals had them in stock. The
facility managers at the chemical shops and pharma-
cies offered reasonable explanations for not having
injectables.
“We do not give injections here. When clients come we tell
them to go to the hospital or clinic. Those are the places
where injections are given.” (pharmacy assistant)
“The injectables belong to the hospitals and clinics. We
refer anyone who comes asking for some to those
places.” (chemical assistant)
The emergency contraceptives was available primarily in
private health facilities such as pharmacies (75 %) and LCS
(69 %). At the bivariate level, emergency contraceptives
were less likely to be found in public health facilities
(OR = 0.11, p = 0.05) (Table 2).
Fig. 1 Contraceptives available in private and public health facilities
Table 2 Comparison of availability of modern contraceptives in
public and private health facilities: Univariable and Multiple
Logistic Regression
Contraceptive type available OR1 [95 % CI] OR2 [95 % CI]
Combined oral contraceptive
Private 1
Public 0.58 [0.10–3.50] 0.63 [0.33–11.84]
Progestin only
Private 1
Public 7.60* [1.43–40.39] 0.30 [0.02–4.71]
Male condoms
Private 1
Public 0.80 [0.14–4.62] 0.30 [0.01–7.46]
Implants
Private 1
Public 5.85* [1.01–34.10] 3.24 [0.11–93.07]
Copper IUD
Private 1
Public 5.85* [1.01–34.10] 3.24 [0.11–93.07]
For the multiple regression the following categories of contraceptives: the
combined oral contraceptives, the male condoms, the implants and the
copper IUD contained three predictor variables namely, the type of facility (eg
LCS, pharmacy) under each health institution, the last time the facility was
stocked with contraceptives and the average number of clients. The progestin
only contraceptive contained two predictor variables namely the type of
facility (eg LCS, pharmacy) under each health institution and the average
number of clients per day
OR1 Odds Ratio for univariable logistic regression, OR2 Odds Ratio for multiple
logistic regression analysis, CI1 &CI2 95 % Confidence Interval for OR1 & OR2
*P value significant at 0.05
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The increase use of emergency contraceptives in private
health facilities such as LCS and pharmacies was summed
up by one of the facility mangers as follows:
“Most of the clients like the emergency contraceptives.
I know someone who takes it virtually every day. She
claims she can enjoy sex with her boyfriend and still
prevent pregnancy.” (pharmacy assistant)
One of the facility managers at the public health facilities
also had this to say about the emergency contraceptives:
“The clients abuse them when we give it to them.
In order not for them to abuse it we do not sell the
emergency contraceptives.” (public health nurse)
The Jadelle implants and the copper IUDs were the
long-acting reversible contraceptives (LARC) identi-
fied in both private and public health facilities. There
were no LARC methods available in pharmacies and
LCS. The implant was not available in the public hos-
pital compared with 33 % of the private hospitals.
Forty three percent (43 %) of both private and public
clinics/maternity homes had implants. The copper IUD
was available in twenty eight (28 %) of the private clinics/
maternity homes as compared with 43 % public clinics/ma-
ternity homes. There was no statistically significant rela-
tionship between the availability of implants and copper
IUDs and type of health facility (public/private). One of the
main reasons for the low availability of LARC methods in
both public and private health facilities particularly the hos-
pitals and clinics/maternity was summarized by a facility
manager as follows;
“No one in this unit has been trained to do insertion of
the IUDs or implants. My immediate boss will soon
undergo the training but till then we do not sell the
implants or IUDs.” (public health nurse)
Facility managers’ perspectives on factors affecting the
availability of contraceptives in public and private health
as perceived by facility managers
This study sought to determine why these facilities sold
the particular type of contraceptives they had in stock.
The major factors or themes that emerged from these dis-
cussions were ‘policies’, ‘training’, ‘competition’, ‘preference’
‘demand’, ‘profit’ and ‘infrastructure’. Some of the facility
managers talked extensively about these factors.
Demand- “The demand of the people determines what
we have. We sell what people ask for. Some of these
contraceptives do not sell fast and if you stock them
they might expire.”(pharmacy assistant)
Preference- “The females themselves do not like the
female condoms. They say it is difficult and unpleasant
to use them and they prefer them as bangles. I only
have a sample just for display.”(public health nurse)
Policy- “The pharmacy council does not allow us to sell
certain drugs so we cannot sell injections” (chemical
shop owner)
Infrastructure- “We do not have a place specifically for
family planning. The maternity ward also doubles as
the family planning unit. Plans are underway to put in
place a family planning unit” (medical assistant)
Discussion
In the Ga East municipality of Ghana where this survey
was carried out, eleven categories of modern contracep-
tive methods were identified ranging from combined
oral contraceptives to spermicides.
For the private health facilities such as pharmacies and
LCS, the combined oral contraceptives, the emergency
contraceptives and the male condoms were the most
available contraceptives compared with other modern
contraceptives such as injectables and LARCs. The most
available modern contraceptive in the public health facil-
ities was the injectables and it was the only method
available in all the public hospitals and clinics (100 %) in
the municipality. Contrary to expectations, one private
pharmacy also had available the injectables. None of the
LCS had injectables available.
Hong et al. [19] lists the most available modern methods
of contraceptives in Ghana as the pills, the injectables
and the male condoms.
Findings from our study however indicates that the in-
jectables might be available only to women who patronize
public health facilities but not to those who patronize pri-
vate health facilities like LCS and pharmacies. From the dis-
cussions with the facility managers, it was clear that the
injectables were not available because of policies which do
not allow the sale of these modern contraceptives in phar-
macies and LCS.
In Ghana, LCS are on the increase and evidence shows
that more women are patronizing these services [20].
Lebetkin et al. [20] recently in their study have shown
that it is possible to equip these facilities to effectively
administer these injectables. It would be great if policies
surrounding the sale of these injectables are therefore
re-looked at to enable the sale of these injectables at
LCS and pharmacies. Safer and easier to handle in-
jectables such as ‘sayana press’ which has also been
shown to work in some selected countries can also be
introduced to these facilities to increase the availabil-
ity of injectables to women who patronize LCS and
pharmacies [21].
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The availability of long acting reversible contraceptives
(LARC) methods such as the implants and the copper
IUDs in this study was low with only 7 out of the 51
health facilities (14 %) having them in stock. None of
chemical shops and pharmacies sampled had these
LARC methods. The levenogestrel IUD was also not
available in any of the health facilities surveyed. The fa-
cility managers in the LCS and pharmacies attributed
this to policies on the sale of these LARC whilst those in
the public hospitals and clinics attributed this to the lack
of trained personnel on the insertion of these methods.
This observation highlights a growing challenge observed
by Aryeetey et al. [6] in which it was made apparent that
awareness of LARC methods in the Ga East municipality
was low. It also adds to the growing perception that this
is one of the key barriers that need to be addressed in
order to increase the utilization of contraceptives in
Ghana and in particular public health facilities, is the
health service barrier [6, 15]. It also underlines the
problem of inadequately trained staff in insertion of
these methods since these methods can only be inserted
in facilities with trained providers [15]. Findings from
this study also suggest the utility of motivating an in-
crease the number of private hospitals and clinics/ ma-
ternity homes as well as public hospitals and clinics/
maternity health centres which offer family planning in
the municipality if there is to be an increase in availabil-
ity of LARC methods since these methods require sur-
gical procedures that can be carried out only in these
types of facilities. The introduction of the CHPs con-
cept in this area and the probable setting up of CHPs
compounds in the municipality is a step in the right
direction.
Finally, this present study also demonstrated the dif-
ferent brands of contraceptives under each category of
contraceptive identified. Secure was discovered as the
most available brand of contraceptive pills particularly
in private health facilities. This is in accordance with
the Ghana Demographic and Health Survey [9] which
reports that Secure is the most popular brand of
contraceptive pills in Ghana. Other contraceptive pills
identified during this study include, Microgynon, Blue,
Yasmin, Primolut-n, Overette, Microlut and Micronor.
The Ghana Demographic and Health Survey [9] con-
firms the availability of these brands in Ghana in
addition to other brands such as Lo-femenal, My pearl,
N/M, OC, Duofem, Oral, Skill and Hot which were not
identified in the health facilities sampled for this
study. A limitation of our study which was the small
number of public health facilities available and hence
a small sample of facilities were used could account
for this. Nevertheless, the absence of other brands of
contraceptive pills in this study as compared to the
Ghana Demographic and Health Survey [9] could be
an indication of the decline in the options available to
users of this method particularly in this municipality
and this could cause a subsequent decline in its use.
Conclusions
This comparative study on the availability of modern con-
traceptives in both private and public health facilities has
brought to light the low availability of some contraceptives
particularly the female condom and LARC methods such
as implants and IUDs in these facilities.
This study has also revealed the high availability of
methods such as emergency contraceptives and spermi-
cides in private institutions as compared with public
ones. Methods such as the injectables are more available
in public health facilities compared with private ones.
Recommendations
We recommend that policies regarding the sale of inject-
ables in LCS and pharmacies be re-looked at to increase
availability and possible use of these methods. Increasing
the number of trained personnel in LARC methods in
both private and public hospitals as well as clinic/maternity
homes may positively affect their availability in the
currently authorized outlets.
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